scholarly article | Q13442814 |
P2093 | author name string | Valeriy V Smirnov | |
Ayodele O Kolawole | |||
Ian M Chrisman | |||
Brian P Hixon | |||
Laura S Dameron | |||
P2860 | cites work | Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O2 incorporation by a heme-containing dioxygenase | Q28115622 |
A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors | Q28237835 | ||
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor | Q28249782 | ||
1-Methyl-DL-tryptophan, beta-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase | Q28333967 | ||
Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia | Q33798508 | ||
Heme-Containing Oxygenases | Q34114428 | ||
Hypoxia abrogates antichlamydial properties of IFN-γ in human fallopian tube cells in vitro and ex vivo | Q34320598 | ||
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. | Q34394487 | ||
Heme enzyme structure and function | Q34396417 | ||
Redox and spectroscopic properties of human indoleamine 2,3-dioxygenase and a His303Ala variant: implications for catalysis | Q34462364 | ||
Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects | Q34535629 | ||
Regulation of IDO activity by oxygen supply: inhibitory effects on antimicrobial and immunoregulatory functions | Q34722824 | ||
Reassessment of the reaction mechanism in the heme dioxygenases. | Q34960294 | ||
The expanded biology of serotonin | Q34993925 | ||
Evidence for a ferryl intermediate in a heme-based dioxygenase. | Q35006504 | ||
Indoleamine 2,3 dioxygenase and regulation of T cell immunity | Q36255493 | ||
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4. | Q36973676 | ||
NADH oxidase activity of indoleamine 2,3-dioxygenase | Q38673283 | ||
Inhibitory substrate binding site of human indoleamine 2,3-dioxygenase | Q39948793 | ||
Indoleamine 2,3-dioxygenase. Kinetic studies on the binding of superoxide anion and molecular oxygen to enzyme | Q40217520 | ||
The mechanism of substrate inhibition in human indoleamine 2,3-dioxygenase | Q41173924 | ||
Spectroscopic studies of ligand and substrate binding to human indoleamine 2,3-dioxygenase | Q41842668 | ||
Enzyme kinetic and spectroscopic studies of inhibitor and effector interactions with indoleamine 2,3-dioxygenase. 1. Norharman and 4-phenylimidazole binding to the enzyme as inhibitors and heme ligands | Q42199358 | ||
Enzyme kinetic and spectroscopic studies of inhibitor and effector interactions with indoleamine 2,3-dioxygenase. 2. Evidence for the existence of another binding site in the enzyme for indole derivative effectors | Q42199359 | ||
The interpretation of non-hyperbolic rate curves for two-substrate enzymes. A possible mechanism for phosphofructokinase | Q42588021 | ||
Probing the ternary complexes of indoleamine and tryptophan 2,3-dioxygenases by cryoreduction EPR and ENDOR spectroscopy | Q42734142 | ||
In vitro modulation of cytochrome P450 reductase supported indoleamine 2,3-dioxygenase activity by allosteric effectors cytochrome b(5) and methylene blue | Q43153054 | ||
Enzyme activities involved in tryptophan metabolism along the kynurenine pathway in rabbits | Q43691769 | ||
Novel protein modification by kynurenine in human lenses | Q43811221 | ||
The role of serine 167 in human indoleamine 2,3-dioxygenase: a comparison with tryptophan 2,3-dioxygenase | Q44577588 | ||
The roles of superoxide anion and methylene blue in the reductive activation of indoleamine 2,3-dioxygenase by ascorbic acid or by xanthine oxidase-hypoxanthine | Q45006905 | ||
Cytochrome b5, not superoxide anion radical, is a major reductant of indoleamine 2,3-dioxygenase in human cells | Q46734158 | ||
Relevance of free tryptophan in serum to tissue tryptophan concentrations | Q48502802 | ||
Human lens coloration and aging. Evidence for crystallin modification by the major ultraviolet filter, 3-hydroxy-kynurenine O-beta-D-glucoside. | Q50515936 | ||
Spectroscopic and equilibrium properties of the indoleamine 2,3-dioxygenase-tryptophan-O2 ternary complex and of analogous enzyme derivatives. Tryptophan binding to ferrous enzyme adducts with dioxygen, nitric oxide, and carbon monoxide. | Q50907206 | ||
Tryptophan pyrrolase of rabbit intestine. D- and L-tryptophan-cleaving enzyme or enzymes. | Q50978363 | ||
Substrate Inhibition in Human Indoleamine 2,3-Dioxygenase. | Q53065949 | ||
Recombinant human erythrocyte cytochrome b5. | Q54627159 | ||
Simultaneous measurement of serum tryptophan and kynurenine by HPLC | Q61906305 | ||
The effect of hormones and vitamin B6 on urinary excretion of metabolites of the kynurenine pathway | Q68528934 | ||
Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures | Q69005518 | ||
Indoleamine 2,3-dioxygenase. Equilibrium studies of the tryptophan binding to the ferric, ferrous, and CO-bound enzymes | Q71133159 | ||
The oxygenated form of L-tryptophan 2,3-dioxygenase as reaction intermediate | Q71571885 | ||
Hypoxia regulates the production and activity of glucose transporter-1 and indoleamine 2,3-dioxygenase in monocyte-derived endothelial-like cells: possible relevance to infantile haemangioma pathogenesis | Q82253873 | ||
Cytochrome b(5) is a major reductant in vivo of human indoleamine 2,3-dioxygenase expressed in yeast | Q83015185 | ||
Resonance Raman study on the oxygenated and the ferryl-oxo species of indoleamine 2,3-dioxygenase during catalytic turnover | Q83414265 | ||
Turn off the IDO: will clinical trials be successful? | Q84780721 | ||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 47-57 | |
P577 | publication date | 2015-02-21 | |
P1433 | published in | Archives of Biochemistry and Biophysics | Q635818 |
P1476 | title | Catalytic activity of human indoleamine 2,3-dioxygenase (hIDO1) at low oxygen | |
P478 | volume | 570 |
Q42316481 | A short history of heme dioxygenases: rise, fall and rise again |
Q49279893 | Different Mechanisms of Catalytic Complex Formation in Two L-Tryptophan Processing Dioxygenases |
Q39093352 | Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance. |